Enzymotec to Report Second Quarter 2016 Financial Results

Enzymotec Ltd., (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid based nutritional ingredients and medical foods, announced today that the Company will release financial results for the second quarter ended June 30, 2016 on Tuesday, August 9, 2016, before the market opens. Following the release, Dr. Ariel Katz, President and Chief Executive Officer, and Oren Bryan, Vice President and Chief Financial Officer, will host a conference call to review the financial results.                                                                                                                                                                              The conference call is scheduled to begin at 8:30 a.m. ET on Tuesday, August 9, 2016. Participants should dial [phone] (United States) or [phone] (International) with confirmation code #56299910 to access the live call. The call will also be broadcast live over the Internet, hosted in the Investors section of Enzymotec's website at http://edge.media-server.com/m/p/j58zacv2, and will be archived online within one hour of its completion.

About Enzymotec Ltd.

Enzymotec is a leading global supplier of specialty lipid-based products and solutions. The Company develops, manufactures, and markets innovative bio-active lipid based nutritional ingredients and medical foods, driven by a deep core of cutting-edge, proprietary technologies intended to improve people’s health. For more information, visit www.enzymotec.com.

Contact:
The Ruth Group
Tram Bui / Lee Roth
[phone] / 7012
[e-mail]
[e-mail]